Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HØJELSE HESTEKLINIK ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.3% 7.4% 2.2% 1.5% 1.3% 1.0% 10.5% 10.4%   Credit score (0-100)   44 34 67 76 77 86 23 5   Credit rating   BB BB BBB BBB BBB A B B   Credit limit (kDKK)   0.0 0.0 0.1 21.6 73.3 319.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,000 4,468 5,725 6,628 7,824 6,637 0.0 0.0   EBITDA   1,084 850 1,849 2,622 3,241 2,138 0.0 0.0   EBIT   922 668 1,788 2,390 3,078 1,826 0.0 0.0   Pre-tax profit (PTP)   669.3 415.5 1,515.0 2,109.8 2,804.2 1,673.4 0.0 0.0   Net earnings   483.4 320.0 1,175.6 1,638.5 2,194.7 1,311.1 0.0 0.0   Pre-tax profit without non-rec. items   669 416 1,515 2,110 2,804 1,673 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   4,060 4,119 4,778 4,869 4,940 4,628 0.0 0.0   Shareholders equity total   619 233 1,168 2,280 3,286 3,553 2,183 2,183   Interest-bearing liabilities   3,564 3,388 3,209 3,034 2,877 2,703 0.0 0.0   Balance sheet total (assets)   8,444 8,623 10,737 11,987 11,118 11,007 2,183 2,183   Net Debt   2,396 2,884 1,509 755 2,099 1,681 -2,183 -2,183     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,000 4,468 5,725 6,628 7,824 6,637 0.0 0.0   Gross profit growth   19.4% -10.6% 28.2% 15.8% 18.0% -15.2% -100.0% 0.0%   Employees   10 12 12 10 12 12 0 0   Employee growth %   42.9% 20.0% 0.0% -16.7% 20.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,444 8,623 10,737 11,987 11,118 11,007 2,183 2,183   Balance sheet change%   13.1% 2.1% 24.5% 11.6% -7.3% -1.0% -80.2% 0.0%   Added value   921.7 667.7 1,787.8 2,389.6 3,078.3 1,826.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -276 -123 598 -142 -92 -623 -4,628 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   18.4% 14.9% 31.2% 36.1% 39.3% 27.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.0% 8.2% 18.7% 21.2% 26.9% 16.5% 0.0% 0.0%   ROI %   22.3% 16.4% 39.9% 43.8% 49.8% 27.9% 0.0% 0.0%   ROE %   124.9% 75.1% 167.9% 95.0% 78.9% 38.3% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   7.3% 2.7% 10.9% 19.1% 31.1% 33.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   221.1% 339.3% 81.6% 28.8% 64.8% 78.6% 0.0% 0.0%   Gearing %   575.8% 1,454.6% 274.8% 133.1% 87.6% 76.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.9% 8.3% 8.8% 9.6% 10.1% 5.6% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   1.0 0.8 0.9 1.0 1.1 1.1 0.0 0.0   Current Ratio   1.1 1.0 1.0 1.2 1.4 1.4 0.0 0.0   Cash and cash equivalent   1,168.7 503.6 1,700.7 2,278.9 778.3 1,022.9 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   422.4 -173.1 173.8 971.9 1,577.2 1,869.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   92 56 149 239 257 152 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   108 71 154 262 270 178 0 0   EBIT / employee   92 56 149 239 257 152 0 0   Net earnings / employee   48 27 98 164 183 109 0 0